Who is on it, and how far along Every drug ChEMBL records acting on BLA, by the furthest stage it has reached for any use, coloured by modality.
How to read this Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
Approved6 Clavulanic acid Clavulanic acid SponsorJohnson & Johnson ModalitySmall molecule ActionInhibitor Open trials58 Tazobactam Tazobactam SponsorMerck & Co. (MSD) ModalitySmall molecule ActionInhibitor Open trials51 Avibactam Avibactam SponsorWockhardt ModalitySmall molecule ActionInhibitor Open trials32 Sulbactam Sulbactam SponsorAnabio R&D ModalitySmall molecule ActionInhibitor Open trials22 Enmetazobactam Enmetazobactam SponsorOrchid Pharma ModalitySmall molecule ActionInhibitor Open trials2 Relebactam anhydrous Relebactam anhydrous SponsorMerck & Co. (MSD) ModalitySmall molecule ActionInhibitor Open trials1
Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. All act as: Bacterial beta-lactamase TEM inhibitor. The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 32 in all, from ClinicalTrials.gov. Trial Drug Phase Status Lead sponsor First posted A Superiority Study of Model-Guided Optimized Dosing Versus Empirical Dosing of Piperacillin/Tazobactam in the Treatment of Community-Acquired Pneumonia in Elderly Patients Tazobactam Phase 2 Recruiting Shandong University Nov 18, 2026 Prospective Randomized Trial Protocol for Duration of Post-Operative Tazocin Treatment After Whipple Operation Tazobactam Phase 4 Recruiting Tel-Aviv Sourasky Medical Center Nov 16, 2026 Probiotic Bifidobacterium Breve PRL2020 in Oral Drops in Preventing Side Effects From Amoxicillin or Amoxicillin/Clavulanic Acid Antibiotic Use Clavulanic acid Not applicable Not yet recruiting Liaquat University of Medical & Health Sciences Nov 13, 2026 Safety Assessment of Placing a Single Dental Implant Without Antibiotic Prophylaxis in Simple Cases: A Pilot Study Clavulanic acid Not applicable Not yet recruiting University of Medicine and Pharmacy at Ho Chi Minh City Nov 5, 2026 Real-world Effectiveness of Cefiderocol Versus Aztreonam/Avibactam Avibactam — Active, not recruiting University Hospital Virgen de las Nieves Nov 2, 2026 Targeted Antimicrobial Comparison for Treatment Individualization in Critically Ill Patients With CRAB Infection Sulbactam — Not yet recruiting Central South University Oct 29, 2026 Antibiotic Tissue Penetration and Tissue Response in Head and Neck Infection and Reconstructive Surgery Clavulanic acid Phase 4 Recruiting Tejs Ehlers Klug Oct 26, 2026 Aztreonam-Avibactam in Immunocompromised Hosts Avibactam — Recruiting Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno Oct 22, 2026 Cefepime-Zidebactam Versus Ceftazidime-Avibactam With or Without Colistin for Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia Avibactam Phase 3 Not yet recruiting Wockhardt Oct 21, 2026 Amoxicillin-clavulanate Versus Amoxicillin Versus Placebo in Acute Otitis Media in Children Clavulanic acid Phase 4 Not yet recruiting Kuopio University Hospital Oct 16, 2026 Comparison of Topical Antibiotics Versus Systemic Antibiotics in Preventing Burn Wound Infection in Pediatric Burn Patients Clavulanic acid Not applicable Not yet recruiting abdul mateen Oct 13, 2026 Piperacillin/Tazobactam Versus Ceftriaxone and Metronidazole for Children With Perforated Appendicitis Tazobactam Phase 3 Not yet recruiting McMaster Children's Hospital Oct 9, 2026 Patient Choice Between Antibiotics and Appendectomy in Uncomplicated Appendicitis (FRENCH 47 - ALACARTE) Clavulanic acid Phase 2 Not yet recruiting Assistance Publique - Hôpitaux de Paris Oct 5, 2026 Prophylactic Antibiotic Duration in Head and Neck Cancer Surgery (PROTECT-HN Trial) Sulbactam Phase 3 Recruiting AC Camargo Cancer Center Oct 1, 2026 This is a Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ertapenem-zidebactam Versus Ceftazidime-Avibactam in the Treatment of Hospitalized Adult Patients With Complicated Urinary Tract Infection or Acute Pyelonephritis Avibactam Phase 2 Not yet recruiting Wockhardt Sep 24, 2026 Tissue Penetration of Antibiotics in CriTically Ill Children Clavulanic acid, Tazobactam — Recruiting University Hospital, Ghent Sep 16, 2026 Resistance-Optimised Antimicrobial Dosing in Critically Ill Patients, a Randomised Controlled Trial Tazobactam Not applicable Not yet recruiting The University of Queensland Sep 15, 2026 Differentiating True Nephrotoxicity From Pseudo-nephrotoxicity: A Prospective Comparative Study of Vancomycin Plus Piperacillin-Tazobactam vs. Meropenem Using Serum Creatinine and Cystatin-C Tazobactam — Recruiting King Faisal Specialist Hospital & Research Center Sep 14, 2026 Effectiveness of Saccharomyces Boulardii in Prevention of Antibiotic Associated Diarrhea Clavulanic acid Not applicable Not yet recruiting University of Child Health Sciences and Children's Hospital, Lahore Aug 25, 2026 Impact of Hypoalbuminemia on Cefoperazone/Sulbactam Induced Coagulopathy in Post-Operative Surgical Patients Sulbactam — Not yet recruiting Sheikh Zayed Federal Postgraduate Medical Institute Aug 19, 2026 Targeted Versus Standard Peri-operative Antibiotic Prophylaxis in Patients Colonized With Carbapenemase Producing Enterobacterales Undergoing Liver Transplantation Avibactam, Relebactam anhydrous, Tazobactam Phase 3 Not yet recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna Aug 12, 2026 Cefepime/Enmetazobactam for Bacteremic Complicated Urinary Tract Infections Enmetazobactam — Not yet recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna Jul 24, 2026 Ceftazidime-Avibactam PK/PD and Resistance in Hematology Patients Avibactam — Not yet recruiting Sizhou Feng Jul 14, 2026 INterest of the Negative Predictive Value of Integrons in the reduCtion of Large Broad-spectrum anTibiotics Consumption for Urinary Tract infectionS Tazobactam Not applicable Recruiting University Hospital, Limoges Jun 30, 2026 Self-Start Triage Model for Post-Botox® Lower Urinary Tract Symptoms Sulbactam Early phase 1 Recruiting The Cleveland Clinic Jun 15, 2026 A Clinical Study of YK-1169 Versus Ceftazidime-Avibactam in Adults With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia Avibactam Phase 3 Not yet recruiting Nanjing Yoko Biomedical Co., Ltd. Jun 8, 2026 Sulbactam-Durlobactam in CRAB Infection: A Real-World Cohort Study Sulbactam — Recruiting Sichuan Provincial People's Hospital May 22, 2026 One Versus Five Days of Antibiotics After Appendectomy Sulbactam Not applicable Not yet recruiting Ministry of Health and Population, Egypt May 4, 2026 Individualized Precision Therapy With Ceftazidime and Avibactam Guided by PK/PD in Geriatric Populations Avibactam — Not yet recruiting Chinese PLA General Hospital Mar 27, 2026 Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial Sulbactam Phase 2 Not yet recruiting The University of Queensland Mar 20, 2026 Assessing Role of Probiotics in Children Aged 6-36 Months Treated for Pneumonia Sulbactam Not applicable Not yet recruiting Anabio R&D Feb 10, 2026 A Study to Investigate PK, Safety, Tolerability of Cefepime-enmetazobactam in Pediatric Participants With cUTI Enmetazobactam Phase 2 Recruiting Orchid Pharma Europe GmbH Apr 24, 2023
Show all 32Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2364670 , ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov , checked daily; this page as of 2026-11-22. ChEMBL and Open Targets